Therefore, even as an independent predictor for future cancer diagnosis in the patient with abdominal symptoms who have ruled out a CRC, the determination of serum CEA should not be used as triage tool to identify who could benefit from further diagnostic tests in this population. This evidence concerns the gene CEACAM5 and colorectal carcinoma.